Drug Profile
Aprepitant topical - LEO Pharma
Alternative Names: Aprepitant gel - LEO PharmaLatest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator LEO Pharma
- Class Anti-inflammatories; Antidepressants; Antiemetics; Antineoplastics; Antitussives; Antivirals; Fluorobenzenes; Ketones; Morpholines; Skin disorder therapies; Small molecules; Triazoles
- Mechanism of Action Neurokinin 1 receptor antagonists; Peptide hydrolase inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pruritus
Most Recent Events
- 19 Feb 2016 No recent reports on development identified - Phase-II for Pruritus in Germany (Topical)
- 01 Jul 2014 LEO Pharma completes the phase II iTAPP trial in Pruritus in Germany (NCT01963793)
- 31 Oct 2013 Phase-II clinical trials in Pruritus in Germany (Topical) (NCT01963793)